New product approvals are further contributing towards the ventricular drainage sets market growth. For instance, in 2017, Arkis BioScience, an innovator and provider of minimally invasive surgical instrumentation and catheters for surgeries, received FDA clearance for its product, CerebroFlo, a new external ventricular catheter.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients